Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

Experimental transfusion-induced Babesia microti infection: dynamics of parasitemia and immune responses in a rhesus macaque model.

Gumber S, Nascimento FS, Rogers KA, Bishop HS, Rivera HN, Xayavong MV, Devare SG, Schochetman G, Amancha PK, Qvarnstrom Y, Wilkins PP, Villinger F.

Transfusion. 2016 Jun;56(6 Pt 2):1508-19. doi: 10.1111/trf.13521. Epub 2016 Feb 19.

2.

Improving liver disease outcomes: four decades of advances in diagnostics technology.

Dawson GJ, Schochetman G.

MLO Med Lab Obs. 2013 Mar;45(3):22-4. No abstract available.

PMID:
23822029
3.

CDC recommends expanded patient testing.

Dawson G, Schochetman G.

MLO Med Lab Obs. 2012 Oct;44(10):16-7. No abstract available.

PMID:
23091956
4.

In-depth investigation of archival and prospectively collected samples reveals no evidence for XMRV infection in prostate cancer.

Lee D, Das Gupta J, Gaughan C, Steffen I, Tang N, Luk KC, Qiu X, Urisman A, Fischer N, Molinaro R, Broz M, Schochetman G, Klein EA, Ganem D, Derisi JL, Simmons G, Hackett J Jr, Silverman RH, Chiu CY.

PLoS One. 2012;7(9):e44954. doi: 10.1371/journal.pone.0044954. Epub 2012 Sep 18.

5.

Sexual Transmission of XMRV: A Potential Infection Route.

Sharma P, Rogers KA, Suppiah S, Molinaro RJ, Onlamoon N, Hackett J Jr, Schochetman G, Klein EA, Silverman RH, Villinger F.

Adv Virol. 2011;2011:965689. doi: 10.1155/2011/965689. Epub 2011 Jul 24.

6.

Xenotropic murine leukemia virus-related virus does not pose a risk to blood recipient safety.

Dodd RY, Hackett J Jr, Linnen JM, Dorsey K, Wu Y, Zou S, Qiu X, Swanson P, Schochetman G, Gao K, Carrick JM, Krysztof DE, Stramer SL.

Transfusion. 2012 Feb;52(2):298-306. doi: 10.1111/j.1537-2995.2011.03450.x. Epub 2011 Nov 21.

PMID:
22098340
7.

Seroprevalence of xenotropic murine leukemia virus-related virus in normal and retrovirus-infected blood donors.

Qiu X, Swanson P, Tang N, Leckie GW, Devare SG, Schochetman G, Hackett J Jr.

Transfusion. 2012 Feb;52(2):307-16. doi: 10.1111/j.1537-2995.2011.03395.x. Epub 2011 Oct 24.

PMID:
22023235
8.

In vivo hypermutation of xenotropic murine leukemia virus-related virus DNA in peripheral blood mononuclear cells of rhesus macaque by APOBEC3 proteins.

Zhang A, Bogerd H, Villinger F, Das Gupta J, Dong B, Klein EA, Hackett J Jr, Schochetman G, Cullen BR, Silverman RH.

Virology. 2011 Dec 5;421(1):28-33. doi: 10.1016/j.virol.2011.08.030. Epub 2011 Oct 6.

9.

No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected.

Knox K, Carrigan D, Simmons G, Teque F, Zhou Y, Hackett J Jr, Qiu X, Luk KC, Schochetman G, Knox A, Kogelnik AM, Levy JA.

Science. 2011 Jul 1;333(6038):94-7. doi: 10.1126/science.1204963. Epub 2011 May 31.

10.

Infection, viral dissemination, and antibody responses of rhesus macaques exposed to the human gammaretrovirus XMRV.

Onlamoon N, Das Gupta J, Sharma P, Rogers K, Suppiah S, Rhea J, Molinaro RJ, Gaughan C, Dong B, Klein EA, Qiu X, Devare S, Schochetman G, Hackett J Jr, Silverman RH, Villinger F.

J Virol. 2011 May;85(9):4547-57. doi: 10.1128/JVI.02411-10. Epub 2011 Feb 16.

11.

A metagenomic analysis of pandemic influenza A (2009 H1N1) infection in patients from North America.

Greninger AL, Chen EC, Sittler T, Scheinerman A, Roubinian N, Yu G, Kim E, Pillai DR, Guyard C, Mazzulli T, Isa P, Arias CF, Hackett J, Schochetman G, Miller S, Tang P, Chiu CY.

PLoS One. 2010 Oct 18;5(10):e13381. doi: 10.1371/journal.pone.0013381.

12.

Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studies.

Qiu X, Swanson P, Luk KC, Tu B, Villinger F, Das Gupta J, Silverman RH, Klein EA, Devare S, Schochetman G, Hackett J Jr.

Retrovirology. 2010 Aug 17;7:68. doi: 10.1186/1742-4690-7-68.

13.

Evaluation of a new third-generation ARCHITECT rHTLV-I/II assay for blood screening and diagnosis.

Kapprell HP, Stieler M, Oer M, Goller A, Hausmann M, Schochetman G, Devare SG, Qiu X.

Diagn Microbiol Infect Dis. 2010 May;67(1):61-9. doi: 10.1016/j.diagmicrobio.2009.12.021. Epub 2010 Mar 12.

PMID:
20227221
14.

Identification of human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains in United States blood donors.

Brennan CA, Stramer SL, Holzmayer V, Yamaguchi J, Foster GA, Notari Iv EP, Schochetman G, Devare SG.

Transfusion. 2009 Jan;49(1):125-33. doi: 10.1111/j.1537-2995.2008.01935.x. Epub 2008 Oct 2.

PMID:
18954404
15.

The prevalence of diverse HIV-1 strains was stable in Cameroonian blood donors from 1996 to 2004.

Brennan CA, Bodelle P, Coffey R, Devare SG, Golden A, Hackett J Jr, Harris B, Holzmayer V, Luk KC, Schochetman G, Swanson P, Yamaguchi J, Vallari A, Ndembi N, Ngansop C, Makamche F, Mbanya D, Gürtler LG, Zekeng L, Kaptué L.

J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):432-9. doi: 10.1097/QAI.0b013e31818a6561.

PMID:
18931623
16.

Evaluation of a new, fully automated immunoassay for detection of HTLV-I and HTLV-II antibodies.

Qiu X, Hodges S, Lukaszewska T, Hino S, Arai H, Yamaguchi J, Swanson P, Schochetman G, Devare SG.

J Med Virol. 2008 Mar;80(3):484-93. doi: 10.1002/jmv.21083.

PMID:
18205214
17.

Performance evaluation of the new fully automated human immunodeficiency virus antigen-antibody combination assay designed for blood screening.

Sickinger E, Jonas G, Yem AW, Goller A, Stieler M, Brennan C, Hausmann M, Schochetman G, Devare SG, Hunt JC, Kapprell HP, Bryant JD.

Transfusion. 2008 Apr;48(4):584-93. doi: 10.1111/j.1537-2995.2007.01583.x. Epub 2008 Jan 11.

PMID:
18194389
18.

Immunoblot assay using recombinant antigens as a supplemental test to confirm the presence of antibodies to Trypanosoma cruzi.

Cheng KY, Chang CD, Salbilla VA, Kirchhoff LV, Leiby DA, Schochetman G, Shah DO.

Clin Vaccine Immunol. 2007 Apr;14(4):355-61. Epub 2007 Feb 7.

19.

Evaluation of a prototype Trypanosoma cruzi antibody assay with recombinant antigens on a fully automated chemiluminescence analyzer for blood donor screening.

Chang CD, Cheng KY, Jiang LX, Salbilla VA, Haller AS, Yem AW, Bryant JD, Kirchhoff LV, Leiby DA, Schochetman G, Shah DO.

Transfusion. 2006 Oct;46(10):1737-44. Erratum in: Transfusion. 2006 Oct;46(10):1852.

PMID:
17002630
20.

HIV-1 Group N: evidence of ongoing transmission in Cameroon.

Yamaguchi J, McArthur CP, Vallari A, Coffey R, Bodelle P, Beyeme M, Schochetman G, Devare SG, Brennan CA.

AIDS Res Hum Retroviruses. 2006 May;22(5):453-7.

PMID:
16706623
21.

HIV global surveillance: foundation for retroviral discovery and assay development.

Brennan CA, Bodelle P, Coffey R, Harris B, Holzmayer V, Luk KC, Swanson P, Yamaguchi J, Vallari A, Devare SG, Schochetman G, Hackett J Jr.

J Med Virol. 2006;78 Suppl 1:S24-9.

PMID:
16622874
22.

HIV variants and hepatitis B surface antigen mutants: diagnostic challenges for immunoassays.

Schochetman G, Kuhns MC.

J Med Virol. 2006;78 Suppl 1:S3-6. No abstract available.

PMID:
16622869
23.

Identification of HIV type 1 group N infections in a husband and wife in Cameroon: viral genome sequences provide evidence for horizontal transmission.

Yamaguchi J, Coffey R, Vallari A, Ngansop C, Mbanya D, Ndembi N, Kaptué L, Gürtler LG, Bodelle P, Schochetman G, Devare SG, Brennan CA.

AIDS Res Hum Retroviruses. 2006 Jan;22(1):83-92. Erratum in: AIDS Res Hum Retroviruses. 2006 Apr;22(4):373.

PMID:
16438650
24.

HIV infections in northwestern Cameroon: identification of HIV type 1 group O and dual HIV type 1 group M and group O infections.

Yamaguchi J, Bodelle P, Vallari AS, Coffey R, McArthur CP, Schochetman G, Devare SG, Brennan CA.

AIDS Res Hum Retroviruses. 2004 Sep;20(9):944-57.

PMID:
15585082
25.

Evaluation of the sensitivity and specificity of six HIV combined p24 antigen and antibody assays.

Ly TD, Laperche S, Brennan C, Vallari A, Ebel A, Hunt J, Martin L, Daghfal D, Schochetman G, Devare S.

J Virol Methods. 2004 Dec 15;122(2):185-94.

PMID:
15542143
26.

Identification and genomic sequence of an HIV type 1 group N isolate from Cameroon.

Bodelle P, Vallari A, Coffey R, McArthur CP, Beyeme M, Devare SG, Schochetman G, Brennan CA.

AIDS Res Hum Retroviruses. 2004 Aug;20(8):902-8.

PMID:
15320995
27.

Enzyme-linked immunosorbent assays using recombinant envelope protein expressed in COS-1 and Drosophila S2 cells for detection of West Nile virus immunoglobulin M in serum or cerebrospinal fluid.

Muerhoff AS, Dawson GJ, Dille B, Gutierrez R, Leary TP, Gupta MC, Kyrk CR, Kapoor H, Clark P, Schochetman G, Desai SM.

Clin Diagn Lab Immunol. 2004 Jul;11(4):651-7.

28.

Experimental infection of rhesus macaques with West Nile virus: level and duration of viremia and kinetics of the antibody response after infection.

Ratterree MS, Gutierrez RA, Travassos da Rosa AP, Dille BJ, Beasley DW, Bohm RP, Desai SM, Didier PJ, Bikenmeyer LG, Dawson GJ, Leary TP, Schochetman G, Phillippi-Falkenstein K, Arroyo J, Barrett AD, Tesh RB.

J Infect Dis. 2004 Feb 15;189(4):669-76. Epub 2004 Feb 4.

PMID:
14767821
29.

Multicenter evaluation of a new, automated enzyme-linked immunoassay for detection of human immunodeficiency virus-specific antibodies and antigen.

Sickinger E, Stieler M, Kaufman B, Kapprell HP, West D, Sandridge A, Devare S, Schochetman G, Hunt JC, Daghfal D; AxSYM Clinical Study Group.

J Clin Microbiol. 2004 Jan;42(1):21-9.

30.

Naturally occurring sequence polymorphisms within HIV type 1 group O protease.

Luk KC, Kaptué L, Zekeng L, Soriano V, Gürtler L, Devare SG, Schochetman G, Hackett J Jr.

AIDS Res Hum Retroviruses. 2001 Nov 1;17(16):1555-61.

PMID:
11709100
31.

Seven human immunodeficiency virus (HIV) antigen-antibody combination assays: evaluation of HIV seroconversion sensitivity and subtype detection.

Ly TD, Martin L, Daghfal D, Sandridge A, West D, Bristow R, Chalouas L, Qiu X, Lou SC, Hunt JC, Schochetman G, Devare SG.

J Clin Microbiol. 2001 Sep;39(9):3122-8.

32.

Quantification of HIV-1 group M (subtypes A-G) and group O by the LCx HIV RNA quantitative assay.

Swanson P, Harris BJ, Holzmayer V, Devare SG, Schochetman G, Hackett J Jr.

J Virol Methods. 2000 Sep;89(1-2):97-108.

PMID:
10996643
33.

Comparative performances of an HTLV-I/II EIA and other serologic and PCR assays on samples from persons at risk for HTLV-II infection.

Poiesz BJ, Dube S, Choi D, Esteban E, Ferrer J, Leon-Ponte M, de Perez GE, Glaser J, Devare SG, Vallari AS, Schochetman G.

Transfusion. 2000 Aug;40(8):924-30.

PMID:
10960518
34.

Genetic analysis of human immunodeficiency virus in Abidjan, Ivory Coast reveals predominance of HIV type 1 subtype A and introduction of subtype G.

Ellenberger DL, Pieniazek D, Nkengasong J, Luo CC, Devare S, Maurice C, Janini M, Ramos A, Fridlund C, Hu DJ, Coulibaly IM, Ekpini E, Wiktor SZ, Greenberg AE, Schochetman G, Rayfield MA.

AIDS Res Hum Retroviruses. 1999 Jan 1;15(1):3-9.

PMID:
10024047
35.

HIV type 1 in Thailand, 1994-1995: persistence of two subtypes with low genetic diversity.

Subbarao S, Limpakarnjanarat K, Mastro TD, Bhumisawasdi J, Warachit P, Jayavasu C, Young NL, Luo CC, Shaffer N, Kalish ML, Schochetman G.

AIDS Res Hum Retroviruses. 1998 Mar 1;14(4):319-27.

PMID:
9519893
36.

Serotyping of HIV type 1 infections: definition, relationship to viral genetic subtypes, and assay evaluation. UNAIDS Network for HIV-1 Isolation and Characterization.

Cheingsong-Popov R, Osmanov S, Pau CP, Schochetman G, Barin F, Holmes H, Francis G, Ruppach H, Dietrich U, Lister S, Weber J.

AIDS Res Hum Retroviruses. 1998 Mar 1;14(4):311-8.

PMID:
9519892
37.

Group O human immunodeficiency virus-1 infections.

Jaffe HW, Schochetman G.

Infect Dis Clin North Am. 1998 Mar;12(1):39-46. Review.

PMID:
9494828
38.

Horizontal and vertical transmission of human immunodeficiency virus type 1 dual infections caused by viruses of subtypes B and C.

Janini LM, Tanuri A, Schechter M, Peralta JM, Vicente AC, Dela Torre N, Pieniazek NJ, Luo CC, Ramos A, Soriano V, Schochetman G, Rayfield MA, Pieniazek D.

J Infect Dis. 1998 Jan;177(1):227-31.

PMID:
9419195
39.

Genetic variability of HIV type 1 in Honduras.

Candal DH, Pau CP, Luo CC, Granade T, Stetler H, Amador L, Meza R, Nunez C, Schochetman G, George JR.

AIDS Res Hum Retroviruses. 1997 Oct 10;13(15):1349-50.

PMID:
9339852
40.

HIV type 1 subtypes in Malaysia include B, C, and E.

Brown TM, Robbins KE, Sinniah M, Saraswathy TS, Lee V, Hooi LS, Vijayamalar B, Luo CC, Ou CY, Rapier J, Schochetman G, Kalish ML.

AIDS Res Hum Retroviruses. 1996 Nov 20;12(17):1655-7.

PMID:
8947304
41.

Genetic variability of human immunodeficiency virus type 1 in rural northwest Tanzania.

Robbins KE, Bandea CI, Levin A, Goedert JJ, Blattner WA, Brubaker G, Brown TM, Schochetman G, Kalish ML, Shao J, O'Brien TR.

AIDS Res Hum Retroviruses. 1996 Sep 20;12(14):1389-91. No abstract available.

PMID:
8891120
42.

A highly heterogeneous HIV-1 epidemic in the Central African Republic.

Massanga M, Ndoyo J, Hu DJ, Pau CP, Lee-Thomas S, Hawkins R, Senekian D, Rayfield MA, George JR, Zengais A, Yatere NN, Yossangang V, Samori A, Schochetman G, Dondero TJ.

Emerg Infect Dis. 1996 Jul-Sep;2(3):222-4. No abstract available.

43.

HIV-1 group O virus identified for the first time in the United States.

Rayfield MA, Sullivan P, Bandea CI, Britvan L, Otten RA, Pau CP, Pieniazek D, Subbarao S, Simon P, Schable CA, Wright AC, Ward J, Schochetman G.

Emerg Infect Dis. 1996 Jul-Sep;2(3):209-12. No abstract available.

44.

Surveillance for human immunodeficiency virus type 1 group O infections in the United States.

Pau CP, Hu DJ, Spruill C, Schable C, Lackritz E, Kai M, George JR, Rayfield MA, Dondero TJ, Williams AE, Busch MP, Brown AE, McCutchan FE, Schochetman G.

Transfusion. 1996 May;36(5):398-400.

PMID:
8693502
45.

Evaluation of oligonucleotide probes for the determination of the two major HIV-1 env subtypes in Thailand.

Subbarao S, Luo CC, Limpakarnjanarat K, Bhumisa-wasdi J, Young NL, Mastro TD, Schochetman G, Kalish ML.

AIDS. 1996 Mar;10(3):350-1. No abstract available.

PMID:
8882685
46.

The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention.

Hu DJ, Dondero TJ, Rayfield MA, George JR, Schochetman G, Jaffe HW, Luo CC, Kalish ML, Weniger BG, Pau CP, Schable CA, Curran JW.

JAMA. 1996 Jan 17;275(3):210-6.

PMID:
8604174
47.

Identification of single and dual infections with distinct subtypes of human immunodeficiency virus type 1 by using restriction fragment length polymorphism analysis.

Janini LM, Pieniazek D, Peralta JM, Schechter M, Tanuri A, Vicente AC, dela Torre N, Pieniazek NJ, Luo CC, Kalish ML, Schochetman G, Rayfield MA.

Virus Genes. 1996;13(1):69-81.

PMID:
8938982
48.

Genetic variability of HIV-1.

Subbarao S, Schochetman G.

AIDS. 1996;10 Suppl A:S13-23. Review. No abstract available.

PMID:
8883605
50.

The evolving molecular epidemiology of HIV-1 envelope subtypes in injecting drug users in Bangkok, Thailand: implications for HIV vaccine trials.

Kalish ML, Baldwin A, Raktham S, Wasi C, Luo CC, Schochetman G, Mastro TD, Young N, Vanichseni S, Rübsamen-Waigmann H, et al.

AIDS. 1995 Aug;9(8):851-7.

PMID:
7576318

Supplemental Content

Loading ...
Support Center